Quick Order Cart

Cat. No. ARG32940

ANK3 Knockout HT29 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

The ANK3 Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population in HT29 cells, eliminating ankyrin-G expression. Ankyrin-G scaffolds E-cadherin (CDH1) and Na+/K+-ATPase (ATP1A1) to the actin cytoskeleton, supporting adherens junctions and polarity. ANK3 loss disrupts these functions, creating a model for barrier dysfunction and enhanced motility. These cells are ideal for studying epithelial barrier integrity, adherens junction dynamics, and ANK3 role in Wnt/??-catenin signaling, with relevance to colorectal cancer metastasis. Applications include TEER measurement, wound healing, and analysis of junctional complexes.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HT29

    Gene Name

    ANK3

    Gene Identifier

    NCBI Gene ID 288

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    McCoy's 5A

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

ANK3 Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population in which the ANK3 gene has been disrupted to eliminate ankyrin-G expression. This loss-of-function model is generated in the HT29 human colorectal adenocarcinoma cell line, a widely used epithelial model. The polyclonal format provides a heterogeneous pool of edited cells, enabling population-based studies of gene function while avoiding clonal selection artifacts. This product is specifically designed for researchers investigating the multifaceted roles of ankyrin-G in epithelial cell biology, with emphasis on adherens junction architecture, polarity regulation, and barrier function.

The host HT29 cell line was originally derived from a human colorectal adenocarcinoma and is extensively employed as an intestinal epithelial model. These cells can undergo enterocyte-like differentiation, characterized by polarization, microvilli formation, and brush border enzyme expression, making them suitable for studies of epithelial differentiation and junctional assembly. Their epithelial origin and tumorigenic properties also render them a relevant platform for colorectal cancer research, particularly for dissecting mechanisms of tumor progression and metastasis within a defined cellular context.

ANK3 encodes ankyrin-G, a scaffold protein that anchors membrane proteins to the spectrin-actin cytoskeleton. In epithelial cells, ankyrin-G binds E-cadherin (CDH1) and the Na+/K+-ATPase ??1 subunit (ATP1A1), linking them through ??II-spectrin (SPTBN1) to the actin cytoskeleton (ACTB). This scaffolding stabilizes adherens junctions by associating with ??-catenin (CTNNB1) and ??-catenin (CTNNA1), and it maintains polarized sodium/potassium transport. ANK3 activity is regulated by Wnt signaling, CDK5 phosphorylation, and E-cadherin engagement. Knockout of ANK3 disrupts this anchoring, leading to impaired junction stability and altered epithelial polarity, which may compromise barrier function and promote a migratory phenotype.

In HT29 cells, ANK3 disruption creates a model to interrogate how loss of ankyrin-G impacts intestinal epithelial homeostasis. Because HT29 cells form polarized monolayers, the polyclonal knockout population enables quantitative assessment of barrier integrity via transepithelial electrical resistance (TEER) and permeability assays. Furthermore, the model reveals how junction destabilization influences E-cadherin/??-catenin signaling, a pathway frequently dysregulated in colorectal cancer. The potential for enhanced migratory behavior makes these cells useful for studying colorectal cancer metastasis and for testing compounds that aim to restore epithelial barrier function or impede EMT.

Primary applications include investigation of adherens junction dynamics, epithelial polarity regulation, and the role of ANK3 in Wnt/??-catenin signaling. Standard techniques such as Western blotting for E-cadherin and ??-catenin, immunofluorescence for ankyrin-G, confocal microscopy of F-actin, and co-immunoprecipitation of junctional complexes directly support these studies. Additional functional assays like wound healing, ??-catenin reporter assays, and TEER measurements further enable exploration of migratory and barrier phenotypes. These assets make the model valuable for colorectal cancer research and epithelial biology. For further information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)